Osteomalacia inducida por adefovir en paciente con hepatitis B
Rivas Zavaleta, Mayra Nathali; Guayambuco Romero, Sonia; Calabozo Raluy, Marcelo; Pérez Ruiz, Fernando.
Reumatol. clín. (Barc.)
; 10(2): 120-121, mar.-abr. 2014. ilus
Artículo en Español | IBECS (España) | ID: ibc-119838
Documentos relacionados
Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases.
Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy.
Fanconi Syndrome and Antiretrovirals: It Is Never Too Late.
Discontinuation of tenofovir due to nephrotoxicity: insight into 12 years of clinical practice
Visual Dermatology: Lipodystrophy and Fat Accumulation Associated With Antiretroviral Therapy.
Antiretroviral treatment leading to secondary trimethylaminuria: Genetic associations and successful management with riboflavin.
Antiretroviral drug-drug interactions: A comparison of online drug interaction databases.
The role of integration and clonal expansion in HIV infection: live long and prosper.
The Incidence and Severity of Drug Interactions Before and After Antiretroviral Therapy Simplification in Treatment-Experienced Patients With HIV Infection.
Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.